Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches

Aug.26.2025
Gumipod Accuses Altria of Misusing Confidential Technology for “On!” Nicotine Pouches
Gumipod Group, Ltd. files federal lawsuit against Altria Group for alleged theft of trade secrets in packaging "On!" nicotine pouches.

Key Points: 

 

Plaintiff: UK-based Gumipod Group, Ltd.

Defendants: Altria Group, Inc. and three subsidiaries — Altria Client Services LLC, Helix Innovations LLC (believed to be the owner of the “On!” brand), and Altria Group Distribution Company.

Dispute Origin: After the signing of a confidentiality agreement in 2018, Gumipod provided samples and specifications; Altria announced the collaboration was on hold, but in 2019 launched “On!” nicotine pouches.

Core Allegations: Violations of the Defend Trade Secrets Act (DTSA), violations of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and business conspiracy.

Claims: Cease infringement, compensate for losses and punitive damages, pay legal fees, and obtain a permanent injunction.

 


 

On August 22, 2025, according to documents released by the Eastern District Federal Court of Texas in the United States, Gumipod Group, Ltd., based in London, filed a federal lawsuit against tobacco company Altria Group (Altria Group, Inc.) and several of its subsidiaries. The lawsuit accuses Altria of misappropriating its trade secrets for use in the packaging of its popular “On!” brand nicotine pouch products.

 

The defendants named in the complaint include Altria Group itself, along with its three subsidiaries: Altria Client Services LLC, Helix Innovations LLC (alleged to own the “On!” brand), and Altria Group Distribution Company.

 

According to the filing, Gumipod was founded by Duval Middleton in 2011 and developed an innovative “plastic capsule-style gum container” with a built-in recycling bin, allowing consumers to conveniently dispose of chewed gum.

 

In August 2018, Emily Ornelas, then a procurement analyst for Altria, contacted Middleton through Gumipod’s website. Shortly afterward, Kwazna Downs, then Altria’s purchasing manager, reached out via Facebook, clarifying that Altria’s interest was in applying the technology to “nicotine products derived from oral tobacco,” rather than gum.

 

To advance discussions, the parties signed a Mutual Confidentiality Agreement (MCA). A key clause stipulated that the obligation to protect trade secrets would remain in effect “as long as trade secret protection is still available.” Following this, Gumipod provided Altria with 10 product samples and detailed production specifications. However, in October 2018, Altria abruptly notified Gumipod that the project was “on hold.”

 

Less than a year later, in June 2019, Altria publicly acquired and relaunched the “On!” nicotine pouch brand. Gumipod alleges that it did not discover the misappropriation until August 24, 2022, when former Gumipod employee Julian Hogan forwarded Altria’s internal marketing documents related to “On!” to Middleton. Gumipod claims that these documents demonstrated the use of its proprietary packaging technology in the design and marketing of On! products.

 

From a legal perspective, Gumipod has filed five causes of action: violation of the Defend Trade Secrets Act (DTSA), violation of the Virginia Uniform Trade Secrets Act (VUTSA), breach of contract, unjust enrichment, and violation of the Virginia Business Conspiracy Act.

 

The plaintiff is requesting a jury trial and is seeking court orders requiring Altria and its subsidiaries to:

 

Immediately cease the use and sale of products alleged to infringe Gumipod’s intellectual property;

Compensate Gumipod for actual losses and punitive damages (amount to be determined at trial);

Pay legal fees and court costs;

Grant a permanent injunction prohibiting further use of Gumipod’s trade secrets and technology.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
German Customs Seize 115,800 Vapes in €1.4 Million Tax Case
Germany's Magdeburg Main Customs Office seized 115,800 untaxed e-cigarettes containing a combined 4.366 million mL of e-liquid during four truck inspections between August 10 and September 4, 2026. The seizures prevented an estimated €1.397 million in tax losses and set a record for the customs office's jurisdiction. Criminal proceedings have been initiated against four truck drivers. The case follows a separate German investigation involving more than 7.6 million illicit vapes and an estimated €33.3 million in excise-tax losses.
Enforcement
Oct.13
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea Constitutional Court Upholds Volume-Based E-Liquid Tax, With Challenged Rates at KRW 370 and KRW 628 per Milliliter
South Korea's Constitutional Court has upheld fixed taxes on nicotine-containing e-cigarette liquids based on solution volume, ruling that challenged provisions imposing KRW 370 per milliliter in individual consumption tax and KRW 628 per milliliter in tobacco consumption tax do not violate the Constitution. The cases stemmed from historical disputes involving importers that reported nicotine as being extracted from tobacco stems rather than leaves. South Korea has since broadened its tobacco definition to include synthetic nicotine, while current tax laws provide reduced rates for certain products not derived from tobacco.
Sep.18
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Latest UK ONS Data: Vaping Rate Edges Down to 9.9% in 2025, a Year After Overtaking Cigarette Smoking
Vaping prevalence in Great Britain edged down to 9.9% in 2025 from 10.0% in 2024, with the number of adult users holding at approximately 5.4 million for a second consecutive year, according to the Office for National Statistics (ONS). E-cigarette use had risen from 6.4% in 2020 to 10.0% in 2024, when it exceeded cigarette smoking prevalence for the first time. Cigarette smoking continued to decline to 8.7% in 2025, widening the gap to 1.2 percentage points. Daily vaping declined slightly, while usage among adults aged 25–34 increased despite falling rates in other age groups.
DATA
Oct.14
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07